Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with Pricing
China’s National Reimbursement Drug List (NRDL) 2020: What…
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact that a de facto annual review has…
Save
Share
China: New Year, New Round of Drug Price Cuts
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug expenditures in 2018, the world’s…
Save
Share
Navigating the Increasingly Stormy Waters of US Market Access
Certara's Ulrich Neumann examines some of the major US market access trends of the past few years, including the innovative financing models required…
Save
Share
EUnetHTA’s Uncertain Future & the Evolution of…
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the establishment of a sustainable European…
Save
Share
5 Trends for Life Science Companies to Watch in 2021
After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five predictions (plus one) on the key trends…
Save
Share
Niklas Hedberg – Chair of the Executive Board, EUnetHTA;…
Niklas Hedberg outlines the role of EUnetHTA as both a network and project built up of national HTAs in Europe, the potential for a continent-wide…
Save
Share
Cross Country Collaborations in Europe: The Future of Pricing…
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of collaboration between European countries…
Save
Share
Novartis Oncology President: “If We Offer Pay-For-Performance,…
During the FT Global Pharmaceutical and Biotechnology Conference earlier this month, three industry leaders spoke about innovative reimbursement…
Save
Share
Marcel Plattner – President, vips, Switzerland
Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing…
Save
Share
Axel B Müller – Managing Director, Intergenerika,…
Intergenerika’s Dr Axel B. Müller makes an impassioned case against the introduction of a reference pricing system in Switzerland, arguing that it…
Save
Share
Paying for Cell & Gene Therapy in the USA: Is the Future…
Certara’s Ulrich Neumann looks at the challenges that payment models for cell and gene therapy (CGT) have faced, the multiple models now under…
Save
Share
Has the Time Truly Come for Trudeau’s ‘National Pharmacare’…
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs, Canada has been struggling with the…
Save
Share
Page: 1 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
interviews
{"post_type":["article","interviews","legal_article","facts","infocus","sponsored"],"post_status":"publish","posts_per_page":12,"max_num_pages":-1,"paged":1,"meta_query":[{"key":"related","value":" Pricing","compare":"LIKE"}]}
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT